Excitatory amino acids as a final common pathway for neurologic disorders

New England Journal of Medicine

Volumn 330, Issue 9, 1994, Pages 613-622

  Epstein, Franklin H ^a   Lipton, Stuart A ^b,c,d   Rosenberg, Paul A ^b,d  

^a Children's Hospital ^*

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATE; ALLOPURINOL; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; APTIGANEL; CALCIUM; CALCIUM CHANNEL; DANTROLENE; DEXTROMETHORPHAN; DEXTRORPHAN; DIZOCILPINE; EXCITATORY AMINO ACID RECEPTOR; FELBAMATE; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR ANTAGONIST; GLUTAMIC ACID; GLYCERYL TRINITRATE; IFENPRODIL; KAINIC ACID; KAINIC ACID RECEPTOR; KETAMINE; LIFARIZINE; MAGNESIUM; MEMANTINE; MONOSIALOGANGLIOSIDE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROTOXIN; NIMODIPINE; PHENCYCLIDINE; PHENYTOIN; REMACEMIDE; RILUZOLE; TIRILAZAD; UNINDEXED DRUG; GLUTAMIC ACID DERIVATIVE; N METHYLASPARTIC ACID;

CALCIUM TRANSPORT; DRUG MECHANISM; HUMAN; NEUROLOGIC DISEASE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; BRAIN DISEASE; DRUG EFFECT; ENZYMOLOGY; METABOLISM; NERVE CELL; PHYSIOLOGY; TRANSPORT AT THE CELLULAR LEVEL;

BIOLOGICAL TRANSPORT; BRAIN DISEASES; CALCIUM; GLUTAMATES; GLUTAMIC ACID; HUMAN; N-METHYLASPARTATE; NEURONS; RECEPTORS, GLUTAMATE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028762647     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199403033300907     Document Type: Review

References (89)

1. Choi DW Glutamate neurotoxicity and diseases of the nervous system. Neuron 1988; 1: 623-634
2. Meldrum B, Garthwaite J Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol Sci 1990; 11: 379-387
3. Lipton SA Models of neuronal injury in AIDS: another role for the NMDA receptor? Trends Neurosci 1992; 15: 75-79
4. Gasic GP, Hollmann M Molecular neurobiology of glutamate receptors. Annu Rev Physiol 1992; 54: 507-536
5. Lipton SA, Kater SB Neurotransmitter regulation of neuronal outgrowth, plasticity and survival. Trends Neurosci 1989; 12: 265-270
6. Olney JW. Neurotoxicity of excitatory amino acids. In: McGeer EG, Olney JW, McGeer PL, eds. Kainic acid as a tool in neurobiology. New York: Raven Press, 1978:95-121.
7. Choi DW Glutamate neurotoxicity in cortical cell culture is calcium dependent. Neurosci Lett 1985; 58: 293-297
8. Nakanishi S Molecular diversity of glutamate receptors and implications for brain function. Science 1992; 258: 597-603
9. Donevan SD, Rogawski MA GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responses. Neuron 1993; 10: 51-59
10. Zorumski CF, Yamada KA, Price MT, Olney JW A benzodiazepine recognition site associated with the non-NMDA glutamate receptor. Neuron 1993; 10: 61-67
11. MacDermott AB, Mayer ML, Westbrook GL, Smith SJ, Barker JL NMDA-receptor activation increases cytoplasmic calcium concentration in cultured spinal cord neurones. Nature 1986; 321: 519-522 [Erratum, Nature 1986;321:888.]
12. Hollmann M, Hartley M, Heinemann S Ca2+ permeability of KA-AMPA-gated glutamate receptor channels depends on subunit composition. Science 1991; 252: 851-853
13. Sucher NJ, Lei SZ, Lipton SA Calcium channel antagonists attenuate NMDA receptor-mediated neurotoxicity of retinal ganglion cells in culture. Brain Res 1991; 551: 297-302 [Erratum, Brain Res 1991;559:179.]
14. Bean BP Classes of calcium channels in vertebrate cells. Annu Rev Physiol 1989; 51: 367-384
15. Lipton SA Calcium channel antagonists in the prevention of neurotoxicity. Adv Pharmacol 1991; 22: 271-297
16. Lei SZ, Zhang D, Abele AE, Lipton SA Blockade of NMDA receptor-mediated mobilization of intracellular Ca2+ prevents neurotoxicity. Brain Res 1992; 598: 196-202
17. Frandsen A, Schousboe A Mobilization of dantrolene-sensitive intracellular calcium pools is involved in the cytotoxicity induced by quisqualate and N-methyl-D-aspartate but not by 2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionate and kainate in cultured cerebral cortical neurons. Proc Natl Acad Sci U S A 1992; 89: 2590-2594
18. Buchan AM, Li H, Cho S, Pulsinelli WA Blockade of the AMPA receptor prevents CA1 hippocampal injury following severe but transient forebrain ischemia in adult rats. Neurosci Lett 1991; 132: 255-258
19. Smith SE, Meldrum BS Cerebroprotective effect of a non-N-methyl-D-aspartate antagonist, GYKI 52466, after focal ischemia in the rat. Stroke 1992; 23: 861-864
20. Dubinsky JM, Rothman SM Intracellular calcium concentrations during “chemical hypoxia” and excitotoxic neuronal injury. J Neurosci 1991; 11: 2545-2551
21. Bading H, Ginty DD, Greenberg ME Regulation of gene expression in hippocampal neurons by distinct calcium signaling pathways. Science 1993; 260: 181-186
22. Tymianski M, Charlton MP, Carlen PL, Tator CH Source specificity of early calcium neurotoxicity in cultured embryonic spinal neurons. J Neurosci 1993; 13: 2085-2104
23. Mattson MP, Guthrie PB, Kater SB A role for Na+-dependent Ca2+ extrusion in protection against neuronal excitotoxicity. FASEB J 1989; 3: 2519-2526
24. Randall RD, Thayer SA Glutamate-induced calcium transient triggers delayed calcium overload and neurotoxicity in rat hippocampal neurons. J Neurosci 1992; 12: 1882-1895
25. Dawson TM, Dawson VL, Snyder SH A novel neuronal messenger molecule in brain: the free radical, nitric oxide. Ann Neurol 1992; 32: 297-311
26. Trout JJ, Koenig H, Goldstone AD, Iqbal Z, Lu CY, Siddiqui F N-Methyl-D-aspartate receptor excitotoxicity involves activation of polyamine synthesis: protection by α-difluoromethylornithine. J Neurochem 1993; 60: 352-355
27. Clark GD, Happel LT, Zorumski CF, Bazan NG Enhancement of hippocampal excitatory synaptic transmission by platelet-activating factor. Neuron 1992; 9: 1211-1216
28. Bito H, Nakamura M, Honda Z, Platelet-activating factor (PAF) receptor in rat brain: PAF mobilizes intracellular Ca2+ in hippocampal neurons. Neuron 1992; 9: 285-294
29. Miller B, Sarantis M, Traynelis SF, Attwell D Potentiation of NMDA receptor currents by arachidonic acid. Nature 1992; 355: 722-725
30. Volterra A, Trotti D, Cassutti P, High sensitivity of glutamate uptake to extracellular free arachidonic acid levels in rat cortical synaptosomes and astrocytes. J Neurochem 1992; 59: 600-606
31. Lafon-Cazal M, Pietri S, Culcasi M, Bockaert J NMDA-dependent superoxide production and neurotoxicity. Nature 1993; 364: 535-537
32. Chan PH, Fishman RA. Free fatty acids, oxygen free radicals, and membrane alterations in brain ischemia and injury. In: Plum F, Pulsinelli W, eds. Cerebrovascular diseases. New York: Raven Press, 1985:161-71.
33. Rosen DR, Siddique T, Patterson D, Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993; 362: 59-62
34. Lipton SA, Choi Y-B, Pan Z-H, A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 1993; 364: 626-632
35. Dawson VL, Dawson TM, London ED, Bredt DS, Snyder SH Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc Natl Acad Sci U S A 1991; 88: 6368-6371
36. Tomei LD, Cope FO, eds. Apoptosis: the molecular basis of cell death. Plainview, N.Y.: Cold Spring Harbor Laboratory Press, 1991.
37. Kane DJ, Sarafian TA, Anton R, Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science 1993; 262: 1274-1277
38. Choi DW, Maulucci Gedde M, Kriegstein AR Glutamate neurotoxicity in cortical cell culture. J Neurosci 1987; 7: 357-368
39. Choi DW Ionic dependence of glutamate neurotoxicity. J Neurosci 1987; 7: 369-379
40. Kvamme E, Schousboe A, Hertz L, Torgner IA, Svenneby G Developmental change of endogenous glutamate and gamma-glutamyl transferase in cultured cerebral cortical interneurons and cerebellar granule cells, and in mouse cerebral cortex and cerebellum in vivo. Neurochem Res 1985; 10: 993-1008
41. Bouvier M, Szatkowski M, Amato A, Attwell D The glial cell glutamate uptake carrier countertransports pH-changing anions. Nature 1992; 360: 471-474
42. Benveniste H, Drejer J, Schousboe A, Diemer NH Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J Neurochem 1984; 43: 1369-1374
43. Rosenberg PA, Amin S, Leitner M Glutamate uptake disguises neurotoxic potency of glutamate agonists in cerebral cortex in dissociated cell culture. J Neurosci 1992; 12: 56-61
44. Storck T, Schulte S, Hofmann K, Stoffel W Structure, expression, and functional analysis of a Na+-dependent glutamate/aspartate transporter from rat brain. Proc Natl Acad Sci U S A 1992; 89: 10955-10959
45. Pines G, Danbolt NC, Bjoras M, Cloning and expression of a rat brain L-glutamate transporter. Nature 1992; 360: 464-467
46. Kanai Y, Hediger MA Primary structure and functional characterization of a high-affinity glutamate transporter. Nature 1992; 360: 467-471
47. Szatkowski M, Barbour B, Attwell D Non-vesicular release of glutamate from glial cells by reversed electrogenic glutamate uptake. Nature 1990; 348: 443-446
48. Kimelberg HK, Goderie SK, Higman S, Pang S, Waniewski RA Swelling-induced release of glutamate, aspartate, and taurine from astrocyte cultures. J Neurosci 1990; 10: 1583-1591
49. Bliss TVP, Collingridge GL A synaptic model of memory: long-term potentiation in the hippocampus. Nature 1993; 361: 31-39
50. Rothman SM, Thurston JH, Hauhart RE Delayed neurotoxicity of excitatory amino acids in vitro. Neuroscience 1987; 22: 471-480
51. Monyer H, Giffard RG, Hartley DM, Dugan LL, Goldberg MP, Choi DW Oxygen or glucose deprivation-induced neuronal injury in cortical cell cultures is reduced by tetanus toxin. Neuron 1992; 8: 967-973
52. Faden AI, Demediuk P, Panter SS, Vink R The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science 1989; 244: 798-800
53. Wrathall JR, Teng YD, Choiniere D, Mundt DJ Evidence that local non-NMDA receptors contribute to functional deficits in contusive spinal cord injury. Brain Res 1992; 586: 140-143
54. Rothman S Synaptic release of excitatory amino acid neurotransmitter mediates anoxic neuronal death. J Neurosci 1984; 4: 1884-1891
55. Schousboe A Transport and metabolism of glutamate and GABA in neurons are glial cells. Int Rev Neurobiol 1981; 22: 1-45
56. Rothstein JD, Tabakoff B Alteration of striatal glutamate release after glutamine synthetase inhibition. J Neurochem 1984; 43: 1438-1446
57. Nicklas WJ, Vyas I, Heikkila RE Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. Life Sci 1985; 36: 2503-2508
58. Turski L, Bressler K, Rettig KJ, Loschmann PA, Wachtel H Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists. Nature 1991; 349: 414-418
59. Sonsalla PK, Zeevalk GD, Manzino L, Giovanni A, Nicklas WJ MK-801 fails to protect against the dopaminergic neuropathology produced by systemic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice or intranigral 1-methyl-4-phenylpyridinium in rats. J Neurochem 1992; 58: 1979-1982
60. Beal MF, Hyman BT, Koroshetz W Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases? Trends Neurosci 1993; 16: 125-131
61. Faden AI, Demediuk P, Panter SS, Vink R The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science 1989; 244: 798-800
62. Lipton SA Molecular mechanisms of trauma-induced neuronal degeneration. Curr Opin Neurol Neurosurg 1993; 6: 588-596
63. Regan RF, Choi DW Glutamate neurotoxicity in spinal cord cell culture. Neuroscience 1991; 43: 585-591
64. Wahlestedt C, Golanov E, Yamamoto S, Antisense oligodeoxynucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischaemic infarctions. Nature 1993; 363: 260-263
65. Nowak L, Bregestovski P, Ascher P, Herbet A, Prochiantz A Magnesium gates glutamate-activated channels in mouse central neurones. Nature 1984; 307: 462-465
66. Mayer ML, Westbrook GL, Guthrie PB Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurones. Nature 1984; 309: 261-263
67. Zeevalk GD, Nicklas WJ Evidence that the loss of the voltage-dependent Mg2+ block at the N-methyl-D-aspartate receptor underlies receptor activation during inhibition of neuronal metabolism. J Neurochem 1992; 59: 1211-1220
68. Hahn JS, Aizenman E, Lipton SA Central mammalian neurons normally resistant to glutamate toxicity are made sensitive by elevated extracellular Ca2+: toxicity is blocked by the N-methyl-D-aspartate antagonist MK-801. Proc Natl Acad Sci U S A 1988; 85: 6556-6560
69. Burnashev N, Schoepfer R, Monyer H, Control by asparagine residues of calcium permeability and magnesium blockade in the NMDA receptor. Science 1992; 257: 1415-1419
70. Cole AJ, Saffen DW, Baraban JM, Worley PF Rapid increase of an immediate early gene messenger RNA in hippocampal neurons by synaptic NMDA receptor activation. Nature 1989; 340: 474-476
71. Braughler JM, Hall ED Central nervous system trauma and stroke. I. Biochemical considerations for oxygen radical formation and lipid peroxidation. Free Radic Biol Med 1989; 6: 289-301
72. Smeyne RJ, Vendrell M, Hayward M, Continuous c-fos expression precedes programmed cell death in vivo. Nature 1993; 363: 166-169
73. Chen H-SV, Pellegrini JW, Aggarwal SK, Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity. J Neurosci 1992; 12: 4427-4436
74. MacDonald JF, Miljkovic Z, Pennefather P Use-dependent block of excitatory amino acid currents in cultured neurons by ketamine. J Neurophysiol 1987; 58: 251-266
75. Choi DW Dextrorphan and dextromethorphan attenuate glutamate neurotoxicity. Brain Res 1987; 403: 333-336
76. Wesemann W, Sturm G, Funfgeld EW Distribution of metabolism of the potential anti-parkinson drug memantine in the human. J Neural Transm Suppl 1980; 16: 143-148
77. Seif el Nasr M, Peruche B, Rossberg C, Mennel H-D, Krieglstein J Neuroprotective effect of memantine demonstrated in vivo and in vitro. Eur J Pharmacol 1990; 185: 19-24
78. Erdo SL, Schafer M Memantine is highly potent in protecting cortical cultures against excitotoxic cell death evoked by glutamate and N-methyl-D-aspartate. Eur J Pharmacol 1991; 198: 215-217
79. Goldman RS, Finkbeiner SM Therapeutic use of magnesium sulfate in selected cases of cerebral ischemia and seizure. N Engl J Med 1988; 319: 1224-1225
80. Manchester KS, Jensen FE, Warach S, Lipton SA Chronic administration of nitroglycerin decreases cerebral infarct size. Neurology 1993; 43: Suppl 2: A365-A365 abstract.
81. McCabe RT, Wasterlain CG, Kucharczyk N, Sofia RD, Vogel JR Evidence for anticonvulsant and neuroprotectant action of felbamate mediated by strychnine-insensitive glycine receptors. J Pharmacol Exp Ther 1993; 264: 1248-1252
82. White HS, Wolf HH, Swinyard EA, Skeen GA, Sofia RD A neuropharmacological evaluation of felbamate as a novel anticonvulsant. Epilepsia 1992; 33: 564-572
83. Wasterlain CG, Adams LM, Hattori H, Schwartz PH Felbamate reduces hypoxic-ischemic brain damage in vivo. Eur J Pharmacol 1992; 212: 275-278
84. The American Nimodipine Study Group. Clinical trial of nimodipine in acute ischemic stroke. Stroke 1992; 23: 3-8 [Erratum, Stroke 1992;23:615.]
85. Bensimon G, Lacomblez L, Meininger V, ALS/RILUZOLE Study Group. A controlled trial of Riluzole in amyotrophic lateral sclerosis. N Engl J Med 1994; 330: 585-591
86. Minematsu K, Fisher M, Li L, Effects of a novel NMDA antagonist on experimental stroke rapidly and quantitatively assessed by diffusion-weighted MRI. Neurology 1993; 43: 397-403
87. Carpenter CL, Marks SS, Watson DL, Greenberg DA Dextromethorphan and dextrorphan as calcium channel antagonists. Brain Res 1988; 439: 372-375
88. Rocca WA, Dorsey FC, Grigoletto F, Design and baseline results of the monosialoganglioside early stroke trial: the EST Study Group. Stroke 1992; 23: 519-526
89. Figueras A, Morales-Olivas FJ, Capella D, Palop V, Laporte JR Bovine gangliosides and acute motor polyneuropathy. BMJ 1992; 305: 1330-1331